Landscape Capital Management L.L.C. Invests $324,000 in Agilent Technologies, Inc. (NYSE:A)

Landscape Capital Management L.L.C. acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,183 shares of the medical research company’s stock, valued at approximately $324,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mount Yale Investment Advisors LLC purchased a new stake in Agilent Technologies during the 1st quarter worth about $290,000. Ascent Group LLC boosted its holdings in Agilent Technologies by 9.9% in the first quarter. Ascent Group LLC now owns 2,061 shares of the medical research company’s stock valued at $300,000 after purchasing an additional 186 shares in the last quarter. Bayesian Capital Management LP purchased a new position in Agilent Technologies in the first quarter valued at approximately $1,355,000. Industrial Alliance Investment Management Inc. raised its holdings in Agilent Technologies by 4.2% during the first quarter. Industrial Alliance Investment Management Inc. now owns 5,820 shares of the medical research company’s stock worth $847,000 after purchasing an additional 235 shares in the last quarter. Finally, Ancora Advisors LLC raised its stake in Agilent Technologies by 4.0% during the 1st quarter. Ancora Advisors LLC now owns 7,226 shares of the medical research company’s stock worth $1,051,000 after acquiring an additional 275 shares in the last quarter. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is owned by company insiders.

Agilent Technologies Stock Performance

NYSE A opened at $133.84 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $38.46 billion, a PE ratio of 27.77, a price-to-earnings-growth ratio of 5.81 and a beta of 1.07. The business’s 50-day moving average price is $137.90 and its 200 day moving average price is $137.61. Agilent Technologies, Inc. has a twelve month low of $123.48 and a twelve month high of $155.35.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 annualized dividend and a yield of 0.74%. Agilent Technologies’s dividend payout ratio is 20.54%.

Analyst Ratings Changes

A has been the subject of a number of research analyst reports. Bank of America upped their target price on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Citigroup increased their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Barclays boosted their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “underweight” rating in a research report on Tuesday, October 15th. TD Cowen increased their price objective on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Finally, UBS Group boosted their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average target price of $144.36.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.